Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends
XTalks
AUGUST 2, 2023
They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities. It contains the antiviral medications nirmatrelvir and ritonavir. billion in 2022. and $16,382.51
98 
Let's personalize your content